A. Trevor Ackerman

A. Trevor Ackerman serves as the Vice-President of Global Tax at Amneal Pharmaceuticals, a position held since May 2018 following the business combination with Impax Laboratories, Inc., where Ackerman was the Head of Global Tax from September 2014. With extensive expertise in international, federal, and state tax matters, responsibilities include implementing tax policy, enhancing global tax structure, overseeing tax compliance and audits, and managing transfer pricing policies. Previous roles encompass Chairman of the Middletown Township Board of Auditors, US Tax Controversy and Planning at Zoetis, Director of Tax at KPMG, Senior Attorney with the IRS Office of Chief Counsel, and Transfer Pricing and State Tax Consultant at PricewaterhouseCoopers. A. Trevor Ackerman holds a Bachelor of Science in Economics/Accounting from The Wharton School, a Bachelor of Arts in History from the University of Pennsylvania, and a Juris Doctor in Corporate and Tax Law from Villanova University.